| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.15B | 3.21B | 3.10B | 2.88B | 2.31B |
| Gross Profit | 1.06B | 1.16B | 1.10B | 882.11M | 637.36M |
| EBITDA | 830.08M | 859.38M | 983.48M | 715.18M | 432.65M |
| Net Income | 529.34M | 563.45M | 607.39M | 431.30M | 215.24M |
Balance Sheet | |||||
| Total Assets | 4.46B | 4.35B | 4.43B | 3.96B | 3.40B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 780.88M | 667.16M | 341.54M | 148.66M |
| Total Debt | 40.24M | 121.21M | 167.06M | 275.67M | 273.97M |
| Total Liabilities | 780.07M | 868.24M | 957.06M | 1.05B | 924.09M |
| Stockholders Equity | 3.69B | 3.49B | 3.48B | 2.92B | 2.48B |
Cash Flow | |||||
| Free Cash Flow | 835.01M | 570.14M | 635.47M | 282.09M | -288.38M |
| Operating Cash Flow | 1.06B | 826.95M | 897.60M | 449.32M | 135.27M |
| Investing Cash Flow | -197.07M | -263.29M | -261.90M | -165.45M | -416.83M |
| Financing Cash Flow | -548.07M | -463.90M | -325.22M | -94.43M | -103.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$4.47B | 6.52 | 11.16% | 13.26% | -1.68% | -5.98% | |
73 Outperform | HK$159.52B | 19.54 | 24.34% | 4.35% | 16.74% | 24.19% | |
65 Neutral | HK$43.03B | 12.26 | 12.26% | 1.39% | 11.26% | 15.82% | |
64 Neutral | HK$23.66B | 9.20 | 9.88% | 2.03% | -3.02% | 11.38% | |
62 Neutral | HK$11.92B | 20.26 | 4.89% | 1.02% | 7.11% | 65.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | HK$660.00M | -78.39 | -2.07% | ― | 47.57% | -345.45% |